Uma Madhav Borate MD

PubMed

• Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial.
  Fieke W Hoff, Ying Huang, Rina Li Welkie, Ronan T Swords, Elie Traer
  Blood Cancer Journal. 2025-04-03
• 1 citations
  Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.
  Uma Borate, Kelly Pugh, Allyson Waller, Rina Li Welkie, Ying Huang
  Blood. 2025-03-27
• 2 citations
  Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes.
  Jacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike, Shaun Fleming, Chun Yew Fong
  Blood. 2025-03-13

Journal Articles

• Functional Genomic Landscape of Acute Myeloid Leukaemia  
  Marc M Loriaux, Christopher R Cogle, Patricia Kropf, Daniel A Pollyea, Uma Borate, Michael W Deininger, Nature

Abstracts/Posters

• A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodyspl...
  Uma Borate, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Dose Escalation Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
  Uma Borate, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Framework to Identify and Prioritize Candidate Inherited Myeloid Malignancy Germline Variants Leveraging the BEAT AML Cohort
  Uma Borate, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Precision Medicine Treatment in Older AML: Results of Beat AML Master TrialClinically Relevant Abstract
  Uma Borate, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodyspl...
  Uma Borate, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Newly Diagnosed AML Patient Samples Demonstrate High Degree of Concordance in Identification of Pathogenic Mutations By Next Generation Sequencing (NGS) Performed at E... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• RGL4 over Expression Correlates with Variation in Midostaurin Response in FLT3-ITD Mutant AML Samples 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• A Precision Medicine Heirarchical Classification Developed Using Variant Allele Frequency (VAF) for Treatment of Older Patients (Pts) with Acute Myeloid Leukemia (AML)... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• IDH Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Targeted Therapy in Leukemia 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Join now to see all